Pharmagreen Biotech Inc. (PHBI) — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2022)

-$875.5K

Total Assets (FY2022)

$209.0K

Total Equity (FY2022)

-$1.9M

Cash Flows from Operating Activities (FY2022)

-$426.6K

Source: Pharmagreen Biotech Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.